Matthew T. David - 14 Jan 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Financial Officer
Signature
/s/ Matthew T David
Issuer symbol
CRMD
Transactions as of
14 Jan 2023
Transactions value $
$0
Form type
4
Filing time
18 Jan 2023, 17:53:40 UTC
Previous filing
23 Feb 2022
Next filing
17 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 3.15K 14 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +125K $0.00 125K 14 Jan 2023 Common Stock 125K $4.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.